{
    "Trade/Device Name(s)": [
        "Audit\u2122M MicroCV\u2122 Procalcitonin Linearity Set",
        "Procalcitonin Linearity"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K101434",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042318"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MJX"
    ],
    "Summary Letter Date": "May 21, 2010",
    "Summary Letter Received Date": "May 24, 2010",
    "Submission Date": "May 18, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Procalcitonin"
    ],
    "Specimen Type(s)": [
        "Serum (simulated human patient)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material",
        "Linearity set"
    ],
    "Document Summary": "FDA 510(k) summary for Audit\u2122M MicroCV\u2122 Procalcitonin Linearity Set as assayed quality control material with five levels for clinical chemistry use.",
    "Indications for Use Summary": "Assayed quality control material for Procalcitonin, simulating human patient serum to monitor precision and detect systematic analytical deviations in laboratory testing procedures.",
    "fda_folder": "Clinical Chemistry"
}